;PMID: 7592017
;source_file_1924.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..42] = [t:0..42]
;1)sentence:[e:48..84] = [t:48..84]
;2)sentence:[e:85..87] = [t:85..87]
;3)sentence:[e:88..181] = [t:88..181]
;4)section:[e:185..270] = [t:185..270]
;5)section:[e:274..360] = [t:274..360]
;6)sentence:[e:364..449] = [t:364..449]
;7)sentence:[e:450..568] = [t:450..568]
;8)sentence:[e:569..751] = [t:569..751]
;9)sentence:[e:753..833] = [t:753..833]
;10)section:[e:837..881] = [t:837..881]

;section 0 Span:0..42
;J Antibiot (Tokyo). 1995 Aug;48(8):757-62.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..10] Antibiot) (-LRB-:[11..12] -LRB-)
        (NN:[12..17] Tokyo) (NN:[17..18] -RRB-) (.:[18..19] .)
        (CD:[20..24] 1995) (.:[25..31] Aug;48) (-LRB-:[31..32] -LRB-)
        (CD:[32..33] 8) (-RRB-:[33..34] -RRB-) (CD:[34..38] :757) (::[38..39] -)
        (CD:[39..41] 62) (.:[41..42] .)))

;sentence 1 Span:48..84
;A new aromatase inhibitor, FR901537.
;[54..63]:substance:"aromatase"
;[64..73]:substance:"inhibitor"
;[75..83]:substance:"FR901537"
(SENT
  (NP-HLN
    (NP (DT:[48..49] A) (JJ:[50..53] new) (NN:[54..63] aromatase)
        (NN:[64..73] inhibitor))
    (,:[73..74] ,)
    (NP (NN:[75..83] FR901537))
    (.:[83..84] .)))

;sentence 2 Span:85..87
;I.
(SENT
  (NP-HLN (CD:[85..86] I) (.:[86..87] .)))

;sentence 3 Span:88..181
;Taxonomy, fermentation, isolation,  physiochemical characteristics and
;biological activities.
(SENT
  (NP-HLN
    (NP (NN:[88..96] Taxonomy))
    (,:[96..97] ,)
    (NP (NN:[98..110] fermentation))
    (,:[110..111] ,)
    (NP (NN:[112..121] isolation))
    (,:[121..122] ,)
    (NP (JJ:[124..138] physiochemical) (NNS:[139..154] characteristics))
    (CC:[155..158] and)
    (NP (JJ:[159..169] biological) (NNS:[170..180] activities))
    (.:[180..181] .)))

;section 4 Span:185..270
;Oohata N, Hori Y, Yamagishi Y, Fujita T, Takase S, Yamashita M, Terano H, 
;Okuhara M.
(SEC
  (FRAG (NNP:[185..191] Oohata) (NNP:[192..193] N) (,:[193..194] ,)
        (NNP:[195..199] Hori) (NNP:[200..201] Y) (,:[201..202] ,)
        (NNP:[203..212] Yamagishi) (NNP:[213..214] Y) (,:[214..215] ,)
        (NNP:[216..222] Fujita) (NNP:[223..224] T) (,:[224..225] ,)
        (NNP:[226..232] Takase) (NNP:[233..234] S) (,:[234..235] ,)
        (NNP:[236..245] Yamashita) (NNP:[246..248] M,) (NNP:[249..255] Terano)
        (NNP:[256..258] H,) (NNP:[260..267] Okuhara) (NNP:[268..270] M.)))

;section 5 Span:274..360
;Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,
;Ibaraki,  Japan.
(SEC
  (FRAG (NNP:[274..285] Exploratory) (NNP:[286..294] Research)
        (NNP:[295..307] Laboratories) (,:[307..308] ,) (NNP:[309..317] Fujisawa)
        (NNP:[318..332] Pharmaceutical) (NNP:[333..336] Co.) (,:[336..337] ,)
        (NNP:[338..342] Ltd.) (,:[342..343] ,) (NNP:[344..351] Ibaraki)
        (,:[351..352] ,) (NNP:[354..359] Japan) (.:[359..360] .)))

;sentence 6 Span:364..449
;FR901537 is a new aromatase inhibitor produced by a bacterium Bacillus sp.
;No.  3072.
;[364..372]:substance:"FR901537"
;[382..391]:substance:"aromatase"
;[392..401]:substance:"inhibitor"
(SENT
  (S
    (NP-SBJ (NN:[364..372] FR901537))
    (VP (VBZ:[373..375] is)
      (NP-PRD
        (NP (DT:[376..377] a) (JJ:[378..381] new) (NN:[382..391] aromatase)
            (NN:[392..401] inhibitor))
        (VP (VBN:[402..410] produced)
          (NP (-NONE-:[410..410] *))
          (PP (IN:[411..413] by)
            (NP-LGS
              (NP (DT:[414..415] a) (NN:[416..425] bacterium))
              (NP (NNP:[426..434] Bacillus) (NNP:[435..438] sp.)
                  (NN:[439..442] No.) (CD:[444..448] 3072)))))))
    (.:[448..449] .)))

;sentence 7 Span:450..568
;Structural studies of FR901537 suggested that it was a novel naphthol 
;derivative having pantetheine in its structure.
;[472..480]:substance:"FR901537"
;[511..531]:substance:"naphthol  derivative"
;[539..550]:substance:"pantetheine"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[450..460] Structural) (NNS:[461..468] studies))
      (PP (IN:[469..471] of)
        (NP (NN:[472..480] FR901537))))
    (VP (VBD:[481..490] suggested)
      (SBAR (IN:[491..495] that)
        (S
          (NP-SBJ (PRP:[496..498] it))
          (VP (VBD:[499..502] was)
            (NP-PRD
              (NP (DT:[503..504] a) (JJ:[505..510] novel)
                 (NN:[511..519] naphthol) (NN:[521..531] derivative))
              (VP (VBG:[532..538] having)
                (NP (NN:[539..550] pantetheine))
                (PP (IN:[551..553] in)
                  (NP (PRP$:[554..557] its) (NN:[558..567] structure)))))))))
    (.:[567..568] .)))

;sentence 8 Span:569..751
;FR901537 showed a potent  inhibitory activity against aromatase from human
;placenta or rat ovary, but did  not inhibit the activity of 11
;beta-hydroxylase from bovine adrenal cortex.
;[569..577]:substance:"FR901537"
;[623..632]:substance:"aromatase"
;[704..723]:substance:"11 beta-hydroxylase"
(SENT
  (S
    (NP-SBJ (NN:[569..577] FR901537))
    (VP
      (VP (VBD:[578..584] showed)
        (NP
          (NP (DT:[585..586] a) (JJ:[587..593] potent)
              (JJ:[595..605] inhibitory) (NN:[606..614] activity))
          (PP (IN:[615..622] against)
            (NP
              (NP (NN:[623..632] aromatase))
              (PP (IN:[633..637] from)
                (NP
                  (NP (JJ:[638..643] human) (NN:[644..652] placenta))
                  (CC:[653..655] or)
                  (NP (NN:[656..659] rat) (NN:[660..665] ovary))))))))
      (,:[665..666] ,) (CC:[667..670] but)
      (VP (VBD:[671..674] did) (RB:[676..679] not)
        (VP (VB:[680..687] inhibit)
          (NP
            (NP (DT:[688..691] the) (NN:[692..700] activity))
            (PP (IN:[701..703] of)
              (NP
                (NP (CD:[704..706] 11) (NN:[707..723] beta-hydroxylase))
                (PP (IN:[724..728] from)
                  (NP (JJ:[729..735] bovine) (JJ:[736..743] adrenal)
                      (NN:[744..750] cortex)))))))))
    (.:[750..751] .)))

;sentence 9 Span:753..833
;Lineweaver-Burk plot analysis revealed that FR901537 is a competitive
;inhibitor.
;[797..805]:substance:"FR901537"
;[823..832]:substance:"inhibitor"
(SENT
  (S
    (NP-SBJ
      (NML (NNP:[753..763] Lineweaver) (HYPH:[763..764] -) (NNP:[764..768] Burk))
      (NN:[769..773] plot) (NN:[774..782] analysis))
    (VP (VBD:[783..791] revealed)
      (SBAR (IN:[792..796] that)
        (S
          (NP-SBJ (NN:[797..805] FR901537))
          (PP (VBZ:[806..808] is)
            (NP-PRD (DT:[809..810] a) (JJ:[811..822] competitive)
                    (NN:[823..832] inhibitor))))))
    (.:[832..833] .)))

;section 10 Span:837..881
;PMID: 7592017 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[837..841] PMID) (::[841..842] :) (CD:[843..850] 7592017)
        (-LRB-:[851..852] -LSB-) (NNP:[852..858] PubMed) (HYPH:[859..860] -)
        (NN:[861..868] indexed) (IN:[869..872] for) (NNP:[873..880] MEDLINE)
        (-RRB-:[880..881] -RSB-)))
